SARS-CoV-2, the virus that causes COVID-19 disease is more transmissible, but has a lower mortality rate than its sibling, SARS-CoV, according to a review article published this week in Antimicrobial Agents and Chemotherapy, ...
Mar 26, 2020
0
7
The number of potential therapeutic options for treatment of COVID-19 is growing. Approaches include blocking SARS-CoV-2 from entering cells, disrupting the virus' replication, antivirals, vaccines, and suppressing overactive ...
Mar 26, 2020
0
11
A protein that is critical in controlling replication of West Nile and Zika viruses—and could be important for developing therapies to prevent and treat those viruses—has been identified by a Georgia State University ...
Nov 6, 2019
0
253
Studying how influenza viruses cause disease just got a little easier, thanks to a new tool developed at South Dakota State University.
Aug 2, 2019
0
13
Researchers at LSTM, along with colleagues at the University of Edinburgh and the University Medical Center Utrecht, have looked at the impact of the natural microbial flora or microbiota in the nose and viral co-infection ...
Jul 8, 2019
0
0
While studying one of the smallest DNA viruses known, Sunnie Thompson, Ph.D., may have found a new way to help prevent kidney damage following organ transplant.
May 30, 2019
0
2
The nonstructural protein 1 (NS1) of the dengue virus interacts with another viral protein called NS4A-2K-4B to enable viral replication, according to a study published May 9 in the open-access journal PLOS Pathogens by Ralf ...
May 9, 2019
0
2
Viruses without a preventative vaccine or treatment option pose a looming threat. But for viruses in this category that have already been weaponized and are recognized as human biothreats by the Centers for Disease Control ...
Apr 16, 2019
0
0
Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B (HBV) or hepatitis C (HCV) experienced poor outcomes. In a new study in the Journal of Hepatology, researchers report ...
Mar 14, 2019
0
1
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical ...
Jan 29, 2019
0
5
